Population
In vitro model studying lipoprotein lipase and activator proteins
Comparison
Addition of activator proteins vs Absence of activator protein or presence of…
Design
Preclinical
Authors
Loading...
Preclinical activator effects on lipoprotein lipase warrant no practice change; leaves open therapeutic translation in human dyslipidemia.
Activator proteins like apolipoprotein CII enhance lipoprotein lipase activity by orienting the enzyme and lipid substrate for effective hydrolysis.
Bengtsson et al. (1980) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: